Skip to main content

Advertisement

SpringerLink
Log in

Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1–4 brain metastases

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Patients with limited brain metastases are often candidates for stereotactic radiosurgery (SRS) or whole brain radiotherapy (WBRT). Among patients who receive SRS, the likelihood and timing of salvage WBRT or SRS remains unclear. We examined rates of salvage WBRT or SRS among 180 patients with 1–4 newly diagnosed brain metastases who received index SRS from 2008–2013. Competing risks multivariable analysis was used to examine factors associated with time to WBRT. Patients had non-small cell lung (53 %), melanoma (23 %), breast (10 %), renal (6 %), or other (8 %) cancers. Median age was 62 years. Patients received index SRS to 1 (60 %), 2 (21 %), 3 (13 %), or 4 (7 %) brain metastases. Median survival after SRS was 9.7 months (range, 0.3–67.6 months). No further brain-directed radiotherapy was delivered after index SRS in 55 % of patients. Twenty-seven percent of patients ever received salvage WBRT, and 30 % ever received salvage SRS; 12 % of patients received both salvage WBRT and salvage SRS. Median time to salvage WBRT or salvage SRS were 5.6 and 6.1 months, respectively. Age ≤60 years (adjusted hazard ratio [AHR] = 2.80; 95 % CI 1.05–7.51; P = 0.04) and controlled/absent extracranial disease (AHR = 6.76; 95 % CI 1.60–28.7; P = 0.01) were associated with shorter time to salvage WBRT. Isolated brain progression caused death in only 11 % of decedents. In summary, most patients with 1–4 brain metastases receiving SRS never require salvage WBRT or SRS, and the remainder do not require salvage treatment for a median of 6 months.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Klos KJ, O’Neill BP (2004) Brain metastases. Neurologist 10:31–46

    Article  PubMed  Google Scholar 

  2. Langer CJ, Mehta MP (2005) Current management of brain metastases, with a focus on systemic options. J Clin Oncol 23:6207–6219

    Article  CAS  PubMed  Google Scholar 

  3. Fox BD, Cheung VJ, Patel AJ et al (2011) Epidemiology of metastatic brain tumors. Neurosurg Clin N Am 22:1–6

    Article  PubMed  Google Scholar 

  4. Posner J (1992) Management of brain metastases. Revue Neurologique (Paris) 148:477–487

    CAS  Google Scholar 

  5. Schouten LJ, Rutten J, Huveneers HA et al (2002) Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, lung and melanoma. Cancer 94:2698–2705

    Article  PubMed  Google Scholar 

  6. Aoyama H, Shirato H, Tago M et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs. stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483–2491

    Article  CAS  PubMed  Google Scholar 

  7. Kocher M, Soffietti R, Abacioglu U et al (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 29:134–141

    Article  PubMed  Google Scholar 

  8. Chang EL, Wefel JS, Hess KR et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037–1044

    Article  PubMed  Google Scholar 

  9. Halasz LM, Weeks JC, Neville BA et al (2013) Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States. Int J Radiat Oncol Biol Phys 85:e109–116

    Article  PubMed  Google Scholar 

  10. Andrews DW, Scott CB, Sperduto PW et al (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665–1672

    Article  PubMed  Google Scholar 

  11. Sperduto PW, Shanley R, Luo X et al (2014) Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1–3 brain metastases; poststratified by the graded prognostic assessment (GPA). Int J Radiat Oncol Biol Phys 90:526–531

    Article  PubMed  PubMed Central  Google Scholar 

  12. Arvold ND, Catalano PJ (2015) Local therapies for brain metastases, competing risks, and overall survival. Int J Radiat Oncol Biol Phys 91:718–720

    Article  PubMed  Google Scholar 

  13. DeAngelis LM, Delattre JY, Posner JB (1989) Radiation-induced dementia in patients cured of brain metastases. Neurology 39:789–796

    Article  CAS  PubMed  Google Scholar 

  14. Gondi V, Paulus R, Bruner DW et al (2013) Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214. Int J Radiat Oncol Biol Phys 86:656–664

    Article  PubMed  PubMed Central  Google Scholar 

  15. Soffietti R, Kocher M, Abacioglu UM et al (2013) A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol 31:65–72

    Article  PubMed  Google Scholar 

  16. Sahgal A, Aoyama H, Kocher M et al (2015) Phase III trials of stereotactic radiosurgery with or without whole brain radiotherapy for 1–4 brain metastases: individual patient data meta-analysis. Int J Radiat Oncol Biol Phys 91:710–717

    Article  PubMed  Google Scholar 

  17. Lester SC, Taksler GB, Kuremsky JG et al (2014) Clinical and economic outcomes of patients with brain metastases based on symptoms: an argument for routine brain screening of those treated with upfront radiosurgery. Cancer 120:433–441

    Article  PubMed  Google Scholar 

  18. Shaw E, Scott C, Souhami L et al (2000) Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 47:291–298

    Article  CAS  PubMed  Google Scholar 

  19. Minniti G, Clarke E, Lanzetta G et al (2011) Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis. Radiat Oncol 6:48

    Article  PubMed  PubMed Central  Google Scholar 

  20. Kondziolka D, Parry PV, Lunsford LD et al (2014) The accuracy of predicting survival in individual patients with cancer. J Neurosurg 120:24–30

    Article  PubMed  Google Scholar 

  21. Yamamoto M, Serizawa T, Shuto T et al (2014) Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol 15:387–395

    Article  PubMed  Google Scholar 

  22. Ayala-Peacock DN, Peiffer AM, Lucas JT et al (2014) A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy. Neuro Oncol 16:1283–1288

    Article  PubMed  PubMed Central  Google Scholar 

  23. Mehta MP, Tsao MN, Whelan TJ et al (2005) The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 63:37–46

    Article  PubMed  Google Scholar 

  24. National Comprehensive Cancer Network: The NCCN Central Nervous System Cancers Clinical Practice Guidelines in Oncology, Version 2.2014. http://www.nccn.org. Accessed 16 Mar 2015

  25. Rodrigues G, Warner A, Zindler JD, Slotman BJ, Lagerwaard FJ (2014) A clinical nomogram and recursive partitioning analysis to determine the risk of regional failure after radiosurgery alone for brain metastases. Radiother Oncol 111:52–58

    Article  PubMed  Google Scholar 

  26. Sawrie SM, Guthrie BL, Spencer SA et al (2008) Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone. Int J Radiat Oncol Biol Phys 70:181–186

    Article  PubMed  Google Scholar 

  27. Lorenzoni J, Devriendt D, Massager N et al (2004) Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys 60:218–224

    Article  PubMed  Google Scholar 

  28. Kress MA, Ramakrishna N, Makgoeng SB et al (2012) Physician self-reported treatment of brain metastases according to patients’ clinical and demographic factors and physician practice setting. Radiat Oncol 7:188

    Article  PubMed  PubMed Central  Google Scholar 

  29. Aupérin A, Arriagada R, Pignon JP et al (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 341:476–484

    Article  PubMed  Google Scholar 

  30. Kim DH, Schultheiss TE, Radany EH et al (2013) Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery. J Neurooncol 115:37–43

    Article  CAS  PubMed  Google Scholar 

  31. Sneed PK, Lamborn KR, Forstner JM et al (1999) Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 43:549–558

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Dana-Farber/Brigham & Women’s Cancer Center, Harvard Medical School, 75 Francis Street, ASB1-L2, Boston, MA, 02115, USA

    Yufei Liu, Brian M. Alexander, Margaret C. Horvath, Ayal A. Aizer, Scott Friesen, Edward G. Mannarino, Matthew Wagar, Fred L. Hacker & Nils D. Arvold

  2. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA

    Yu-Hui Chen

  3. Department of Neurosurgery, Dana-Farber/Brigham & Women’s Cancer Center, Harvard Medical School, Boston, MA, USA

    Elizabeth B. Claus, Ian F. Dunn, Alexandra J. Golby & Mark D. Johnson

  4. School of Public Health, Yale University, New Haven, CT, USA

    Elizabeth B. Claus

Authors
  1. Yufei Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brian M. Alexander
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yu-Hui Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Margaret C. Horvath
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ayal A. Aizer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Elizabeth B. Claus
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ian F. Dunn
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Alexandra J. Golby
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Mark D. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Scott Friesen
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Edward G. Mannarino
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Matthew Wagar
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Fred L. Hacker
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Nils D. Arvold
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nils D. Arvold.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, Y., Alexander, B.M., Chen, YH. et al. Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1–4 brain metastases. J Neurooncol 124, 429–437 (2015). https://doi.org/10.1007/s11060-015-1855-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-015-1855-5

Keywords

Search

Navigation